Yubo International Biotech Ltd
YBGJ OTC
SEC CIK 895464
Follow Yubo International Biotech
Weekly email: filings, results
Revenue, last quarter
$0
Net income
−$188.4K
+31.9% vs same quarter last year
EPS, diluted
$0.00
Operating cash flow
−$157
+99.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $12.4K | −$1.1M |
| FY24 | $3.5K | −$1.8M |
| FY23 | $604.7K | −$1.2M |
| FY22 | $104.3K | −$1.2M |
| FY21 | $1.2M | −$1.5M |
| FY20 | $0 | −$711.8K |
| FY19 | $0 | −$148K |
| FY18 | $0 | −$144K |
| FY17 | $0 | −$224K |
| FY16 | $0 | −$130K |
| FY15 | $0 | −$116K |
| FY14 | $0 | −$106K |
| FY13 | - | −$103K |
| FY12 | $0 | −$84K |
| FY11 | $0 | −$110K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 66.1% | −9614.6% | −8736.7% |
| FY24 | 76.3% | −51006.3% | −51171.4% |
| FY23 | 69.3% | −197.6% | −197.6% |
| FY22 | 50.5% | −1155.7% | −1155.5% |
| FY21 | 65.9% | −124% | −124% |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | −$601K |
| FY21 | −$1.6M |
| FY20 | $58.6K |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Yubo International Biotech
- Healthcare median
Show the numbers
| Year | Yubo International Biotech | Healthcare median |
|---|---|---|
| FY25 | −8736.7% | −30.6% |
| FY24 | −51171.4% | −47% |
| FY23 | −197.6% | −58% |
| FY22 | −1155.5% | −80.4% |
| FY21 | −124% | −71.9% |
| FY20 | - | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |